title: [Experience in the therapy of eczema patients].
abstract: Analysis of clinical and laboratory findings permits a conclusion that riboxin in complex with common antiallergic therapy is the most desirable therapy for both true and bacterial eczema. This metabolic exposure results in a much more rapid clinical effect. A good therapeutic effect may be achieved with the use of cinnarizin, though its therapeutic efficacy is inferior to that of riboxin and this drug does not normalize metabolic processes so distinctly.
authors.forename: I V
authors.initials: IV
authors.lastname: Shulina
authors.forename: Iu N
authors.initials: IuN
authors.lastname: Turkevich
authors.forename: A I
authors.initials: AI
authors.lastname: Zaĭchenko
mesh_terms: D000136:Acid-Base Equilibrium / Q000187:drug effects; D001510:Bed Rest; D002936:Cinnarizine / Q000627:therapeutic use; D004341:Drug Evaluation; D004359:Drug Therapy, Combination; D004485:Eczema / Q000188:drug therapy* / Q000378:metabolism; D006801:Humans; D007288:Inosine / Q000627:therapeutic use; D011727:Pyridinolcarbamate / Q000627:therapeutic use; D013607:Tablets; D013997:Time Factors
chemical_list: D013607:Tablets; D002936:Cinnarizine; D007288:Inosine; D011727:Pyridinolcarbamate
vernacular_title: Opyt terapii bol'nykh ékzemoĭ.